Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

Life Science Companies as Investments | Life Science Night Dec. 2, 2024

By Inderes

Antti Siltanen, Life Science Analyst, PhD, talks about life science companies as investments.

Life Science Night
Keynote – Antti Siltanen, Inderes (link)
Aiforia – Jukka Tapaninen, CEO (link)
Herantis Pharma – Antti Vuolanto, CEO (link)
Faron Pharmaceuticals – Juho Jalkanen, CEO (link)

Life Science Night December 2, 2024 (link)
Health Technology & Pharmaceutical Developer Night December 11, 2023 (link)
Health Technology & Pharmaceutical Developer Night December 13, 2022 (link)

Stay up to date
Aiforia Technologies
BBS-Bioactive Bone Substitutes
Bioretec
Biohit
Faron Pharmaceuticals
Modulight
Nexstim
Orion
Bittium
Detection Technology
Optomed
Revenio Group
Nightingale Health
Herantis Pharma
Nanoform Finland
Investor events

Recent videos

UPM and Sappi are planning a joint venture in graphic papers
04.12.2025, 13.00 UPM-Kymmene
GreenMobility: How far away are driverless cars in Denmark
04.12.2025, 11.32 GreenMobility
Systemair, Audiocast, Q2'25/26
04.12.2025, 09.00 Systemair
HCA Morgenbørs 03/12 - Overvejende positive futures og fokus på ISS
03.12.2025, 09.23 Novo Nordisk
Hafnia – Presentation of the quarterly report for Q3 2025
02.12.2025, 11.00 Hafnia
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.